VALIDATE: Virtual Agent Linked Intelligent Disease Assessment Tool Engine
| Status: | Not yet recruiting |
|---|---|
| Conditions: | Cancer, Cancer |
| Therapuetic Areas: | Oncology |
| Healthy: | No |
| Age Range: | 18 - Any |
| Updated: | 5/17/2017 |
| Start Date: | September 1, 2017 |
| End Date: | November 30, 2017 |
| Contact: | Steven Charlap, MD, MBA |
| Email: | scharlap@stanford.edu |
| Phone: | 617-319-6434 |
The collection and analysis of family, medical, lifestyle, and environmental exposure
history (a Comprehensive Health History or "CHH") can identify critical risk factors for
many chronic and life-threatening conditions, including cancer. Despite its importance, CHH
is infrequently documented and analyzed in primary-care medical practice due to numerous
hurdles, and currently available tools have proven inadequate to address this critical
problem. This study will evaluate the Virtual Agent Linked Intelligent Disease Assessment
Tool Engine ("VALIDATE") system as an easy to administer, accurate, cost-effective, and
clinically useful tool for collecting and analyzing structured CHH data.
history (a Comprehensive Health History or "CHH") can identify critical risk factors for
many chronic and life-threatening conditions, including cancer. Despite its importance, CHH
is infrequently documented and analyzed in primary-care medical practice due to numerous
hurdles, and currently available tools have proven inadequate to address this critical
problem. This study will evaluate the Virtual Agent Linked Intelligent Disease Assessment
Tool Engine ("VALIDATE") system as an easy to administer, accurate, cost-effective, and
clinically useful tool for collecting and analyzing structured CHH data.
Our study's objective is to evaluate the Virtual Agent Linked Intelligent Disease Assessment
Tool Engine ("VALIDATE") system as a means to improve the affordability and ease, while
maintaining the validity and feasibility, of collecting, assessing, and acting on
Comprehensive Health History data.
Virtual Agents (VAs) are fully autonomous and embodied software agents that use both verbal
(e.g. speech) and non-verbal modalities (e.g., gaze, gesturing) to simulate a
clinician-patient encounter. These agents have already successfully shown advantages to
patients for: entering family history data on their own, facilitating medication adherence,
providing behavioral health information, serving as clinical interviewers, promoting
breastfeeding, and educating about and motivating exercise and weight loss. The VALIDATE
system has been developed to be a fully automated alternative to the currently extremely
labor-intensive process of collecting and transcribing CHH data. VALIDATE will be evaluated
for its capability to significantly diminish clinician time and cost to collect, review,
analyze, and document accurate and complete certain CHH data directly from patients at home
using their own personal desktop computers. VALIDATE will also be evaluated for its
capability to identify valid clinical action, e.g. referral indications for familial cancer
assessment based on American College of Medical Genetics and Genomics (ACMG)/National
Society of Genetic Counselors (NSGC) and National Comprehensive Care Network (NCCN)
Guidelines.
Tool Engine ("VALIDATE") system as a means to improve the affordability and ease, while
maintaining the validity and feasibility, of collecting, assessing, and acting on
Comprehensive Health History data.
Virtual Agents (VAs) are fully autonomous and embodied software agents that use both verbal
(e.g. speech) and non-verbal modalities (e.g., gaze, gesturing) to simulate a
clinician-patient encounter. These agents have already successfully shown advantages to
patients for: entering family history data on their own, facilitating medication adherence,
providing behavioral health information, serving as clinical interviewers, promoting
breastfeeding, and educating about and motivating exercise and weight loss. The VALIDATE
system has been developed to be a fully automated alternative to the currently extremely
labor-intensive process of collecting and transcribing CHH data. VALIDATE will be evaluated
for its capability to significantly diminish clinician time and cost to collect, review,
analyze, and document accurate and complete certain CHH data directly from patients at home
using their own personal desktop computers. VALIDATE will also be evaluated for its
capability to identify valid clinical action, e.g. referral indications for familial cancer
assessment based on American College of Medical Genetics and Genomics (ACMG)/National
Society of Genetic Counselors (NSGC) and National Comprehensive Care Network (NCCN)
Guidelines.
Inclusion Criteria:
All adults above the age of 18
Exclusion Criteria:
Children under the age of 18
We found this trial at
1
site
211 Quarry Road
Palo Alto, California 94304
Palo Alto, California 94304
Principal Investigator: Nima Aghaeepour, PhD
Phone: 650-723-6028
Click here to add this to my saved trials
